Skip to main content
← All exclusions

Can-Fite Biopharma Ltd

CANF

Health Care

1

exclusion reason

1 theme

Animal Welfare (1)
CANF Health Care Current as of April 2026

This page is part of our public exclusion list — a transparency tool that shows which companies we screen out and why. It is not investment advice, and it is not an accusation. But it is subject to change as our understanding of the facts evolves.

Animal Testing & Research
Since Jan 3, 2022

Can-Fite Biopharma Ltd. is a clinical-stage pharmaceutical company whose drug development pipeline relies on animal testing to meet regulatory requirements for safety and efficacy. The company's lead drug candidates, including Piclidenoson (CF101) and Namodenoson (CF102), have progressed through preclinical studies involving animal models, a standard practice in the biopharmaceutical industry that constitutes commercial exploitation of animals under the firm's exclusion policy. While specific revenue figures from animal-tested products are not publicly broken out, the company's entire business model and valuation are predicated on successfully advancing these candidates through animal-based research stages to reach human clinical trials and eventual market approval.

Research Sources 1 organization
Cruelty Free Investors
External

Wondering what we do invest in?

The Naughty List

A digest of changes to our exclusion list — new additions, removals, and the evidence behind them. We review the list continuously as new evidence surfaces.

RSS feed No spam · Unsubscribe anytime

Companies appear on our exclusion list based on our investment judgment — not because they've done anything illegal. This is a difference of values and opinion, not an accusation of wrongdoing. Exclusion does not constitute a recommendation against investing in any company, and absence from the list does not constitute a recommendation to invest.

This information is provided for educational and transparency purposes only and should not be relied upon as investment advice. Data is drawn from independent watchdogs, NGOs, government registries, and Ethical Capital's ongoing research — see Research Sources for the full list.

Ethical Capital LLC is a state-registered investment adviser in Utah (CRD #316032). Registration does not imply a certain level of skill or training.